Novel rat model of tympanostomy tube otorrhea

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 2, 2012, Pages 179-182

  Silva, Rodrigo C ^a   Dohar, Joseph E ^b,c,d   Hebda, Patricia A ^b,c,d  

^a UNIVERSITY OF FLORIDA   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cytokines; Rat model; Tympanostomy tube otorrhea

Indexed keywords

CIPROFLOXACIN PLUS DEXAMETHASONE; INTERLEUKIN 1BETA; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY TUBE DYSFUNCTION; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE MODEL; INOCULATION; MALE; MIDDLE EAR EFFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STREPTOCOCCUS PNEUMONIAE; TYMPANOSTOMY TUBE OTORRHEA;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EUSTACHIAN TUBE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855942738     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.11.001     Document Type: Article

References (22)

1. Bhattacharyya N. Ambulatory pediatric otolaryngologic procedures in the United States: characteristics and perioperative safety. Laryngoscope 2010, 120:821-825.
2. Ah-Tye C., Paradise J.L., Colborn D.K. Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: prevalence, incidence, and duration. Pediatrics 2001, 107:1251-1258.
3. Mandel E.M., Casselbrant M.L., Kurs-Lasky M. Acute otorrhea: bacteriology of a common complication of tympanostomy tubes. Ann. Otol. Rhinol. Laryngol. 1994, 103:713-718.
4. Ruohola A., Meurman O., Nikkari S., Skottman T., Salmi A., Waris M., et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin. Infect. Dis. 2006, 43:1417-1422.
5. Dohar J. Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy. Int. J. Pediatr. Otorhinolaryngol. 2003, 67:1317-1323.
6. Lim D.J., Hermansson A., Hellström S.O., Hussl B., Alper C.M., Iino Y., et al. Recent advances in otitis media. 3. Animal models; anatomy and pathology; pathogenesis; cell biology and genetics. Ann. Otol. Rhinol. Laryngol. Suppl. 2005, 194:31-41.
7. Kuijpers W., van der Beek J.M., Willart E.C. The effect of experimental tubal obstruction on the middle ear. Preliminary report. Acta Otolaryngol. 1979, 87(3-4):345-352.
8. Hermansson A., Emgård P., Prellner K., Hellström S. A rat model for pneumococcal otitis media. Am. J. Otolaryngol. 1988, 9(3):97-101.
9. Piltcher O.B., Swarts J.D., Magnuson K., Alper C.M., Doyle W.J., Hebda P.A. A rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection: methods and disease course. Otolaryngol. Head Neck Surg. 2002, 126:490-498.
10. Hebda P.A., Piltcher O.B., Swarts J.D., Alper C.M., Zeevi A., Doyle W.J. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope 2002, 112:1657-1662.
11. Soderberg O., Hellstrom S., Stenfors L.E., Thore M. Tympanostomy tubes for prevention of purulent otitis media. Otolaryngol. Head Neck Surg. 1985, 93:601-606.
12. Yellon R.F., Leonard G., Marucha P.T., Craven R., Carpenter R.J., Lehmann W.B., et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991, 101:165-169.
13. Yellon R.F., Doyle W.J., Whiteside T.L., Diven W.F., March A.R., Fireman P. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch. Otolaryngol. Head Neck Surg. 1995, 121:865-869.
14. Sato K., Kawana M., Nonomura N., Nakano Y. Course of IL-1beta, IL-6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae. Ann. Otol. Rhinol. Laryngol. 1999, 108:559-563.
15. Hebda P.A., Alper C.M., Doyle W.J., Burckart G.J., Diven W.F., Zeevi A. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann. Otol. Rhinol. Laryngol. 1998, 107:501-507.
16. Bluestone C.D. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int. J. Pediatr. Otorhinolaryngol. 1998, 42:207-223.
17. Daniel S.J., Kozak F.K., Fabian M.C., Hekkenberg R., Hruby L.E., Harjee K.S., et al. Guidelines for the treatment of tympanostomy tube otorrhea. J. Otolaryngol. 2005, 34(Suppl. 2):S60-S63.
18. Dohar J., Giles W., Roland P., Bikhazi N., Carroll S., Moe R., et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006, 118(3):e561-e569.
19. Roland P.S., Kreisler L.S., Reese B., Hekkenburg R., Lane E.M., Conroy P.J., et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004, 113:e40-e46.
20. Roland P.S., Anon J.B., Moe R.D., Conroy P.J., Wall G.M., Dupre S.J., et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003, 113(12):2116-2122.
21. Dohar J. Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy. Int. J. Pediatr. Otorhinolaryngol. 2003, 67(12):1317-1323.
22. Ruohola A., Meurman O., Nikkari S., Skottman T., Salmi A., Waris M., et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin. Infect. Dis. 2006, 43(11):1417-1422.